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Summary
Paget disease is a common bone disease characterized
by abnormal osteoclasts that are large, multinucleated,
and overactive and that contain paramyxovirus-like
nuclear inclusions. There is evidence for a major genetic
component to Paget disease, with up to 40% of patients
having affected first-degree relatives; however, the locus
(loci) and gene(s) involved are unknown. Another bone
disorder, familial expansile osteolysis (FEO), although
extremely rare, also is characterized by similar osteoclast
abnormalities but has an earlier age at onset and a more
aggressive clinical progression. The causative gene for
FEO has been localized to a region of human
chromosome 18q. On the basis of the presence of similar
clinical findings and of viral-like nuclear inclusions in
osteoclasts, we hypothesized that FEO and Paget disease
are allelic versions of the same locus. Therefore, a large
kindred with a high incidence of Paget disease was
examined to determine if Paget disease was linked to
genetic markers in the same region of chromosome 18
as that for FEO. Our analysis yielded a two-point LOD
score of 3.40, with the genetic marker D18S42, a marker
tightly linked to the FEO locus. This demonstrates that
the gene(s) responsible for FEO and that for Paget
disease are either closely linked or the same locus.
Introduction
Paget disease is one of the most flagrant examples of
disordered bone remodeling, with abnormalities in all
phases of the bone-remodeling process. Paget disease has
an estimated incidence of 3.3% in individuals 140 years
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of age, on the basis of autopsy data (Schmorl 1932). It
is typically a disease found in older persons, and diag-
nosis at !40 years of age is uncommon (Klein and Nor-
man 1995). Although a high proportion of patients with
Paget disease appear asymptomatic, ∼5% present with
pain related to the pagetic process (Klein and Norman
1995). This disease has many other manifestations, in-
cluding increased fractures, deafness, and neurological
complications, as well as osteosarcomas (Hamdy 1995).
The pathophysiological bases for these abnormalities are
not defined clearly, except that the primary cellular ab-
normalities appear to reside in the osteoclasts. Osteo-
clasts in Paget disease are increased in number and in
size and contain paramyxovirus-like nuclear inclusions
(Singer 1996).
Paget disease has a strong familial tendency (Jacobs
et al. 1979; Sofaer et al. 1983; Mirra 1986), suggesting
a genetic component to the disease. In a recent study of
the frequency and characteristics of familial aggregation
of Paget disease in Spain, Morales-Piga et al. (1995)
found that 140% of their index cases had at least one
first-degree relative affected with Paget disease. In the
pedigrees examined, Paget disease appeared to be trans-
mitted by an autosomal dominant mode of inheritance.
Siris (1994) conducted an epidemiological study of Paget
disease in the United States, using questionnaires com-
pleted by 864 patients with physician-diagnosed Paget
disease and by 500 controls of similar ages. A history
of Paget disease was noted in a first-degree relative in
12% of the patients, compared with only 2% of con-
trols. The risk that first-degree relatives of a pagetic pa-
tient will develop Paget disease was seven times greater
than that for an individual without an affected relative.
The cumulative risk for development of Paget disease,
up to 90 years of age, for a first-degree relative of a
patient was 9%, compared with 2% for individuals with
unaffected relatives. Such data provide strong evidence
for genetic factors playing a role in the acquisition of
the disease.
Familial expansile osteolysis (FEO) is an extremely
rare bone dysplasia that is known to be transmitted in
an autosomal dominant fashion in a single large kindred
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Figure 1 Pedigree of kindred with Paget disease. Blackened symbols represent affected individuals. An asterisk (*) indicates those individuals
for whom the phenotype is unknown. The disease haplotype is indicated by a rectangle. The FEO critical region is denoted by a vertical boldface
line to the left of the marker names.
from northern Ireland (Wallace et al. 1989). The path-
ogenesis of FEO is related to Paget disease in several
ways. The histological bone lesions of FEO appear to
be similar to pagetic lesions, although they occur at a
much earlier age and are more severe. Furthermore, as
in Paget disease, the osteoclasts in patients with FEO
contain paramyxoviral-like nuclear inclusions (Dickson
et al. 1991). These similarities suggest that FEO may be
a rare and exaggerated form of Paget disease.
Recently, Hughes et al. (1994) have utilized genetic
linkage analysis of a large kindred in northern Ireland,
to localize FEO to chromosome 18q. The disease shows
tight linkage to several polymorphic markers on chro-
mosome 18q, with a maximum two-point LOD score
of 11.53, with marker D18S64. Using the approach of
linkage analysis, we determined that Paget disease is
linked to the same region of chromosome 18 as that for
FEO, in a single large kindred with Paget disease. This
supports the hypothesis that Paget disease and FEOmay
be allelic versions of the same disorder.
Patients and Methods
Patient Population
We evaluated a large kindred (fig. 1) from Los Angeles
that had migrated from Belize to the United States, over
the past 30 years. This family is of Mayan, Spanish, and
Scottish descent. It is thought that the disease was in-
herited from an ancestor who migrated to Belize from
Scotland, where the incidence of Paget disease is high
(Barker and Gardner 1974). We collected blood samples
from 16 individuals in this kindred, who are x35 years
of age, 8 of whom are diagnosed with Paget disease.
Clinical Evaluation
This study was approved by the Institutional Review
Board of the St. John’s Hospital and Health Center,
Santa Monica, and all participants provided informed
consent. All living participants were evaluated clinically
by one of the authors (F.R.S.), who is an acknowledged
expert in the clinical presentation of Paget disease. In-
dividuals II-4, II-7, III-3, and III-4 were diagnosed with
Paget disease before initiation of this study. All other
living family members were assessed for their disease
status first by measurement of serum alkaline phospha-
tase levels. Those individuals with a clinical indication
of possible Paget disease, such as the presence of a high-
normal or an elevated alkaline phosphate level (190 IU/
liter) or of symptoms that are suggestive of a muscu-
loskeletal disorder, were evaluated further by an x-ray
or a bone scan. Since these techniques involve radiation
exposure, albeit at low levels, these procedures were per-
formed only on those patients with a clinical indication
of possible Paget disease. The deceased members of the
kindred were diagnosed with Paget disease, after ex-
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amination of photographs and from detailed descrip-
tions provided by family members.
Genotypic Analysis
High-molecular-weight DNA was isolated from pe-
ripheral blood samples, in accordance with the methods
of Bell et al. (1981). The DNA samples were genotyped
by use of highly polymorphic PCR-based markers de-
veloped and mapped by Ge´ne´thon (Dib et al. 1996). In
addition, several other microsatellite markers in the re-
gion were utilized (LeBeau et al. 1993). The PCR re-
actions were performed as described elsewhere (Cody et
al. 1997), by use of a total of 12 markers on 18q. The
markers were D18S39, D18S64, D18S38, D18S1134,
D18S499, D18S1147, D18S1148, D18S862, D18S60,
D18S42, D18S51, and D18S55. Genotypic determina-
tions were made without knowledge of disease status.
Linkage Analyses
For linkage analysis, it was assumed that the disease
was inherited in an autosomal dominant mode, and the
disease allele frequency was determined to be 1.5%, on
the basis of a prevalence of 3% in the population
(Schmorl 1932). Individuals were considered to be un-
affected if they had a serum alkaline phosphatase level
!90 IU/liter, had no evidence of a musculoskeletal dis-
ease, and were x35 years of age. On the basis of the
observation of affected-to-unaffected ratios of individ-
uals at risk in this kindred, we have assumed high pen-
etrance (95%) for the disease allele. Allele frequencies
were determined by the typing of 15–25 unrelated in-
dividuals of northern European descent, for all markers
except D18S42. Because the D18S42 allele segregating
with the disease in the family was a very rare allele
(0.96% frequency), 104 chromosomes were used to de-
termine the allele frequencies in unrelated individuals.
All allele frequencies were determined on gels that con-
tained samples from the affected family, which were run
in lanes adjacent to the samples from the unrelated in-
dividuals. The LOD-score calculations were performed
by use of the computer program LINKAGE, version 5.1
(Lathrop et al. 1984).
Results
To determine if a gene for Paget disease of bone resides
on chromosome 18q, we studied a large kindred in
which the disease appears to be inherited in an auto-
somal dominant fashion. This kindred has affected in-
dividuals, in multiple generations, who exhibit trans-
mission through bothmales and females. All participants
were evaluated clinically, with the results summarized in
table 1. Included in table 1 are the results for four family
members (individuals I-2, II-5, II-10, and II-12) who are
deceased and who were diagnosed retrospectively, by
analysis of their history. The clinical severity of Paget
disease in the family ranged from clinically asympto-
matic but with radiological findings (individual III-7) to
the extensive and crippling disabilities of the propositus
(individual III-4, the sister of individual III-7), who had
clinically apparent involvement of several bones, at an
early age.
Since FEO previously had been localized to human
chromosome 18q (Hughes et al. 1994), the DNA from
these individuals was genotyped by use of markers from
18q. For the genotypic analysis performed for their
study, Hughes et al. (1994) used the following markers
in the following order (proximal to distal): D18S35,
D18S64, D18S60, D18S55, D18S42, D18S61, MBP,
D18S43, and D18S70. The FEO gene was flanked by
the recombinant markers D18S35 and D18S61. These
markers, as well as additional polymorphic markers in
the region, were used to analyze the Paget disease kin-
dred. In figure 1, the results of the genotypic analysis
with the seven most informative markers are shown di-
rectly beneath each individual. The disease haplotype is
indicated by a rectangle, in figure 1. However, one in-
dividual (II-3) had a clear diagnosis of Paget disease but
did not possess the disease haplotype.
We obtained a maximum two-point LOD score of
3.40 with genetic marker D18S42, assuming 95% pen-
etrance (table 2). Two-point LOD-score analysis also
was performed with the assumption of a penetrance rate
of 90% (data not shown). This analysis also generated
a LOD score 13 with marker D18S42. However, the
D18S42 allele segregating with the disease in this family
was very rare. A significant LOD score (3.04) also was
obtained with adjacent marker D18S1148. The allele
frequency (21%) for this marker segregating with the
disease indicated that this marker was not rare. The
Paget disease region is bounded proximally by a recom-
bination event at D18S39 (individual III-3). The distal
boundary of the region remains undefined in this family,
so we therefore were unable to determine the size of the
critical region.
Multipoint analysis was performed by use of two ad-
jacent markers in the map order, taken two at a time
with the disease locus. All markers shown in table 2
were utilized, except for marker D18S51. This marker
was excluded from multipoint analysis because its ge-
netic location is not well established. The multipoint
analysis places the disease locus at D18S42 (maximum
LOD score of 3.1).
Discussion
We have performed linkage analysis on a large kindred
in which Paget disease of bone was segregating in an
autosomal dominant fashion. Because of the similarities
between Paget disease and FEO, we postulated that these
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Table 1
Phenotypic Data for Paget Disease Kindred
PATIENT
PRESENT AGE
(years)
AFFECTED
STATUSa
PHENOTYPIC ASSESSMENT
Serum Alkaline Phos-
phatase before
Treatmentb
(IU/liter)
Skeletal Survey/
Bone Scan
Performed Clinical Diagnosis
I-2 Deceased  ND No/no Skull diagnosed retro-
spectively, through
history and
photographs
II-1 76  83 No/no Not affected
II-2 64  84 No/no Not affected
II-3 60  218 Yes/no Pelvis, right and left
femur
II-4 55  1,000 Yes/yes Pelvis, right femur, sa-
crum, thoracic and
lumbar spine, left
humerus
II-5 Deceased  ND No/no Skull diagnosed retro-
spectively, through
history and
photographs
II-7 82  25c Yes/no Pelvis, lumbar spine,
right clavicle, left
humerus
II-10 Deceased  ND No/no Diagnosed retrospec-
tively, through photo-
graphs and family
report
II-13 Deceased  ND No/no Not affected
III-1 53  84 Yes/no Not affected
III-2 35  55 No/no Not affected
III-3 61  220 Yes/yes Skull, left scapula,
sacrum
III-4 (propositus) 60  2,000 Yes/yes Skull, right and left hu-
merus, right ilium,
left patella, right fe-
mur, right and left
tibia, thoracic spine,
lumbar spine
III-5 58  ND Yes/yes Skull, right scapula, left
calcaneus, lumbar
spine, cervical spine
III-6 54  64 Yes/yes Not affected
III-7 50  97 Yes/yes Right and left ischium
III-8 48  329 Yes/no Right femur
III-9 42  77 No/no Not affected
III-10 35  67 No/no Not affected
III-11 51  70 No/no Not affected
a A plus sign () denotes that the patient was affected; a minus sign () denotes that the patient was unaffected.
b Normal level !126 IU/liter. ND  not determined, because the test was not performed.
c Measured at a different laboratory, where normal levels are !3 IU/liter.
two diseases may be allelic, caused by different muta-
tions of the same gene. We therefore genotyped the in-
dividuals in our kindred, with markers for chromosome
18q that were in the region previously determined to be
linked to FEO (Hughes et al. 1994). Hughes et al. (1994)
obtained a maximum LOD score of 11.53 with D18S64,
at 0 recombination, and a LOD score of 10.90 with
D18S42, at 0 recombination, for a large kindred from
northern Ireland (Hughes et al. 1994). We have obtained
a maximum two-point LOD score of 3.40 with D18S42,
demonstrating that Paget disease is linked to the same
region of chromosome 18q as that for FEO. In addition,
Haslam et al. (1997) recently reported, in abstract form,
of the linkage of Paget disease to D18S42, with a max-
Cody et al.: Linkage of Paget Disease of Bone to 18q 1121
Table 2
Two-Point LOD Scores for Paget Disease Kindred, Obtained with
Chromosome 18 Markers
MARKER
LOD SCORE AT RECOMBINATION FRACTION OF
.001 .01 .05 .10 .20 .30 .40
D18S39 .13 .14 .48 .56 .50 .36 .18
D18S64 .45 .61 .87 .91 .75 .48 .20
D18S1147 1.89 2.01 2.13 2.00 1.50 .90 .36
D18S1148 3.04 2.99 2.76 2.47 1.83 1.15 .50
D18S42 3.40 3.34 3.07 2.27 2.01 1.28 .59
D18S51 2.11 2.24 2.37 2.26 1.79 1.20 .57
D18S55 1.63 1.77 1.91 1.81 1.37 .81 .29
imum LOD score of 5.7, determined by use of four kin-
dreds from the United Kingdom. Thus, the combined
LOD score for linkage of Paget disease to marker
D18S42 is 9.1.
The FEO region recently has been narrowed to a chro-
mosome 18 region of ∼4.5 Mb, between markers
D18S64 and D18S51 (Hughes and Barr 1996). There
are several genes that have been identified in this region;
however, none of them are obvious candidate genes for
this disease.
The data in figure 1 show that individual II-3 does
not carry the disease haplotype but meets the disease
criteria for the study. There are at least three possible
explanations for this finding. First, his Paget disease
could be the result of a new mutation of a gene involved
in Paget disease. Second, individual II-3 may have in-
herited the disease gene from his father (individual I-3),
whose phenotype is unknown. If inherited from his fa-
ther, his Paget disease could be due to either a gene at
this locus or, if the disease is genetically heterogeneous,
a gene at another locus. This possibility seems likely,
since the incidence of Paget disease in the general pop-
ulation is relatively high (∼3%). Third, the patient could
have a form of Paget disease that does not have a genetic
cause. It is not possible to determine the relative prob-
ability of these explanations, because no gene(s) has been
identified for Paget disease, and, thus, the rate of new
mutation is unknown.
Individuals who had a high-normal alkaline phos-
phatase level or signs of musculoskeletal disease were
evaluated further by an x-ray or a bone scan. One in-
dividual (III-7) in this kindred had no external signs of
Paget disease, but a bone scan revealed the presence of
two small pagetic lesions in her pelvis. This finding in-
dicates that, although a high serum alkaline phosphatase
level often is associated with the disease, a high-normal
serum alkaline phosphatase level does not exclude the
presence of the disease. This finding also suggests that
the familial nature of Paget disease may not be appre-
ciated fully, since some individuals may have occult pa-
getic lesions.
Owing to the late-onset nature of Paget disease, it is
possible that individuals, in this kindred, who were !45
years of age actually carried the disease gene and were
asymptomatic owing to their age. However, in this fam-
ily, several members had early onset of the disease (!30
years of age). Early onset commonly is observed in ge-
netic forms of common sporadic diseases (Hall et al.
1990).
A viral etiology has been suggested for Paget disease.
In 1974, Rebel et al. (1974) described organized groups
of microcylinders within the nuclei and cytoplasm of
osteoclasts in pagetic bone lesions from patients with
Paget disease and suggested that these may be viral in-
clusions (Rebel et al. 1976; Harvey et al. 1982). These
histological findings were substantiated by Mills and
Singer (1976) and by others (Gherardi et al. 1980;
Vacher-Lavenu et al. 1981), who reported viral inclu-
sions in the osteoclasts from essentially all Paget disease
patients. However, these inclusions are not limited to or
diagnostic of Paget disease. Similar findings of inclusion
bodies have been reported rarely in bone specimens from
patients with giant-cell tumors of the bone (Welsh and
Meyer 1970) and in a few cases of pychodysostosis
(Beneton et al. 1987), osteopetrosis (Mills et al. 1988),
and primary oxalosis (Bianco et al. 1992). These viral-
like inclusions appear to be related to the paramyxovirus
group of viruses, for several reasons. First, the viral-like
inclusion bodies are closely similar in structure to par-
amyxoviruses. Second, these inclusions cross-react with
antibodies against paramyxoviral nucleocapsid antigens.
Third, osteoclasts and their precursor cells from patients
with Paget disease express the measles virus (Reddy et
al. 1995) or the canine-distemper-virus nucleocapsid
mRNA (Gordon et al. 1990).
At present, the gene(s) responsible for Paget disease
is unknown. One possible function of this gene(s), which
may be mutated both in Paget disease and in FEO pa-
tients, is to confer an increased susceptibility, to osteo-
clasts and their precursors, to viral infection by para-
myxovirus. Alternatively, this gene(s) may be involved
in enhanced osteoclast activity or formation.
The identification of a locus on 18q for Paget disease
is the first step toward identification of the gene involved.
The identification of a gene(s) will give important in-
sights into the mechanism underlying the abnormal os-
teoclast activity in Paget disease and the normal bone-
remodeling process. In addition, identification of the
gene(s) for Paget disease could have important thera-
peutic implications for the estimated 2–3million patients
in the United States who have Paget disease.
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